# ABVC BioPharma (ABVC) — News

ABVC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/abvc/news

## Recent headlines

- [AdvancedAdvt Ltd: Hy trading remains in line with management expectations](https://www.ainvest.com/news/advancedadvt-hy-trading-remains-line-management-expectations-2610) — AInvest Wire, Oct 12, 2026
  AdvancedAdvt Ltd (ADVT) continues to report trading performance consistent with management expectations, with no significant deviations noted in recent operations. The company recently completed a share buyback of 243,453 shares , reflecting its ongoing commitment to managing capital structure and…
- **Important** — ABVC Biopharma rockets 99% premarket after  receiving $460M from Aibtl Biopharma as the first milestone payment of global licensing fees — AInvest Wire, Jan 3, 2024
- ABVC BioPharma and its subsidiary receive $460M from Aibtl BioPharma as the first milestone payment of global licensing fees — AInvest Wire, Jan 3, 2024
  ABVC BioPharma and its subsidiary receive $460M from Aibtl BioPharma as the first milestone payment of global licensing fees ABVC BioPharma and its subsidiary, BioLite, have recently received a significant milestone payment of $460 million from AiBtl BioPharma. This payment is the first of…
- **Important** — ABVC BioPharma Shares Rise 8% After U.S. Patent for ADHD Treatment — AInvest Wire, Nov 21, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).